As Jd Com (Put) (JD) Market Value Declined, Point72 Asia Hong Kong LTD Boosted Stake; As Genmark Diagnostics (GNMK) Market Value Rose, Putnam Investments Has Decreased Its Holding by $4.26 Million

JD.com, Inc. (NASDAQ:JD) Logo

Point72 Asia Hong Kong Ltd increased its stake in Jd Com Inc (Put) (JD) by 1740.94% based on its latest 2018Q2 regulatory filing with the SEC. Point72 Asia Hong Kong Ltd bought 70,926 shares as the company’s stock declined 33.02% while stock markets rallied. The hedge fund held 75,000 shares of the consumer services company at the end of 2018Q2, valued at $2.92M, up from 4,074 at the end of the previous reported quarter. Point72 Asia Hong Kong Ltd who had been investing in Jd Com Inc (Put) for a number of months, seems to be bullish on the $30.28B market cap company. The stock decreased 1.41% or $0.3 during the last trading session, reaching $20.93. About 13.48M shares traded. JD.com, Inc. (NASDAQ:JD) has declined 36.17% since December 8, 2017 and is downtrending. It has underperformed by 51.79% the S&P500. Some Historical JD News: 08/05/2018 – EXCLUSIVE-Walmart’s grocery delivery partnerships with Uber, Lyft fail to take off; 29/03/2018 – HNA GROUP, JD.COM SIGN COOPERATION AGREEMENT; 11/05/2018 – Partners Group Adds Black Knight, Exits JD.com: 13F; 16/04/2018 – JD.COM SAYS FILES TO CLARIFY POTENTIAL CONFUSION CAUSED BY CERTAIN STATEMENTS MADE BY CO’S CHIEF EXECUTIVE OFFICER, RICHARD QIANGDONG LIU -SEC FILING; 30/05/2018 – Hedge Tencent, Sell JD.com and Other Ideas From Sohn Hong Kong; 09/05/2018 – SHANDONG DELISI FOOD 002330.SZ SAYS IT SIGNS STRATEGIC AGREEMENT WITH JD.COM TO SELL PRODUCTS ON JD’S E-COMMERCE PLATFORM; 09/05/2018 – JD.com and iQlYl Joint Membership Program Attracts a Combined One Million Users in the First Week; 24/04/2018 – LESHI INTERNET SIGNS STRATEGIC PACT WITH JD.COM UNIT; 08/05/2018 – JD.COM SEES 2Q REV. 120B YUAN TO 124B YUAN, EST. 122.39B YUAN; 16/03/2018 – CHINA’S JD.COM JD.O FINANCE UNIT LOOKING TO RAISE ABOUT $1.9 BLN THAT COULD VALUE IT AT MORE THAN $20 BLN

Putnam Investments Llc decreased its stake in Genmark Diagnostics Inc (GNMK) by 16.11% based on its latest 2018Q2 regulatory filing with the SEC. Putnam Investments Llc sold 710,100 shares as the company’s stock rose 11.08% with the market. The institutional investor held 3.70M shares of the health care company at the end of 2018Q2, valued at $23.59M, down from 4.41 million at the end of the previous reported quarter. Putnam Investments Llc who had been investing in Genmark Diagnostics Inc for a number of months, seems to be less bullish one the $281.46 million market cap company. The stock decreased 2.52% or $0.13 during the last trading session, reaching $5.03. About 376,552 shares traded. GenMark Diagnostics, Inc. (NASDAQ:GNMK) has declined 18.16% since December 8, 2017 and is downtrending. It has underperformed by 33.78% the S&P500. Some Historical GNMK News: 21/04/2018 – DJ GenMark Diagnostics Inc, Inst Holders, 1Q 2018 (GNMK); 24/04/2018 – Nidec To Acquire Genmark Automation, Inc., An US Semiconductor Wafer Handling Robot Manufacturer; 24/04/2018 – GenMark Diagnostics Short-Interest Ratio Rises 48% to 41 Days; 03/05/2018 – GenMark Diagnostics at Bank of America Conference May 16; 27/03/2018 – CASDIN CAPITAL REPORTS A 7 PCT STAKE IN GENMARK DIAGNOSTICS AS OF MARCH 20 – SEC FILING; 01/05/2018 – GenMark Backs FY18 Rev $68M-$72M; 01/05/2018 – GenMark 1Q Loss/Shr 21c; 30/04/2018 – Nidec Completes Acquisition Of Genmark Automation, Inc., A US Semiconductor Wafer Handling Robot Manufacturer; 27/03/2018 Casdin Capital, LLC, Affiliates Report Stake In GenMark; 15/05/2018 – GenMark Diagnostics at Bank of America Conference Tomorrow

More notable recent GenMark Diagnostics, Inc. (NASDAQ:GNMK) news were published by: Globenewswire.com which released: “GenMark Diagnostics Reports Second Quarter 2018 Results Nasdaq:GNMK – GlobeNewswire” on July 30, 2018, also Fool.com with their article: “Why GenMark Diagnostics, Inc. Is Soaring Today – The Motley Fool” published on September 16, 2016, Streetinsider.com published: “After-Hours Stock Movers 05/01: (CRAY) (CYH) (AAPL) Higher; (SNAP) (YUMC) (GILD) Lower (more…) – StreetInsider.com” on May 01, 2018. More interesting news about GenMark Diagnostics, Inc. (NASDAQ:GNMK) were released by: Benzinga.com and their article: “The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs (July 29-Aug. 4) – Benzinga” published on July 28, 2018 as well as Seekingalpha.com‘s news article titled: “GenMark Diagnostics Starting To Deliver, But Consistency Is A Key Issue – Seeking Alpha” with publication date: July 06, 2018.

Putnam Investments Llc, which manages about $89.35B and $43.95 billion US Long portfolio, upped its stake in Jabil Inc (NYSE:JBL) by 226,551 shares to 319,330 shares, valued at $8.83 million in 2018Q2, according to the filing. It also increased its holding in Realogy Holdings Corp (NYSE:RLGY) by 527,629 shares in the quarter, for a total of 903,168 shares, and has risen its stake in Eversource Energy.

Among 6 analysts covering Genmark Diagnostics (NASDAQ:GNMK), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Genmark Diagnostics had 24 analyst reports since October 14, 2015 according to SRatingsIntel. On Friday, November 3 the stock rating was downgraded by Raymond James to “Market Perform”. Canaccord Genuity maintained it with “Buy” rating and $14.0 target in Monday, October 30 report. The firm has “Buy” rating given on Wednesday, October 28 by Needham. Canaccord Genuity maintained the shares of GNMK in report on Monday, June 12 with “Buy” rating. The firm has “Buy” rating given on Monday, June 12 by Needham. Canaccord Genuity maintained the shares of GNMK in report on Friday, June 29 with “Buy” rating. The rating was maintained by Canaccord Genuity with “Buy” on Monday, September 25. Needham maintained the stock with “Buy” rating in Wednesday, October 18 report. Needham maintained the shares of GNMK in report on Wednesday, August 30 with “Buy” rating. The firm has “Buy” rating given on Wednesday, February 24 by Needham.

Since August 17, 2018, it had 0 insider buys, and 30 sales for $319,199 activity. $38,947 worth of GenMark Diagnostics, Inc. (NASDAQ:GNMK) was sold by MASSARANY HANY. Gleeson Michael sold $8,780 worth of stock or 1,814 shares. McNally James B. sold $1,113 worth of stock or 219 shares. Mitchell Brian Andrew sold $3,313 worth of GenMark Diagnostics, Inc. (NASDAQ:GNMK) on Monday, November 5. 1,809 shares were sold by Williams Jennifer Anne, worth $13,369. The insider Stier Eric sold $7,010.

Analysts await GenMark Diagnostics, Inc. (NASDAQ:GNMK) to report earnings on February, 26. They expect $-0.16 earnings per share, up 38.46% or $0.10 from last year’s $-0.26 per share. After $-0.20 actual earnings per share reported by GenMark Diagnostics, Inc. for the previous quarter, Wall Street now forecasts -20.00% EPS growth.

Investors sentiment increased to 1.81 in 2018 Q2. Its up 0.69, from 1.12 in 2018Q1. It increased, as 6 investors sold GNMK shares while 20 reduced holdings. 17 funds opened positions while 30 raised stakes. 49.90 million shares or 1.22% less from 50.51 million shares in 2018Q1 were reported. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Federated Investors Pa stated it has 0% of its portfolio in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Alliancebernstein LP invested in 55,800 shares. Weiss Multi holds 0.03% or 170,000 shares in its portfolio. State Street has 0% invested in GenMark Diagnostics, Inc. (NASDAQ:GNMK) for 1.12 million shares. 2,052 are owned by Bnp Paribas Arbitrage Sa. Northern Tru stated it has 666,351 shares. 6,811 were accumulated by Tci Wealth Advsr. Gabelli Funds Ltd Co owns 10,370 shares. Voya Mgmt Ltd Com, Georgia-based fund reported 19,725 shares. Alyeska Inv Gp LP owns 1.38 million shares. Credit Suisse Ag reported 0% of its portfolio in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Fincl Bank Of Montreal Can stated it has 3,501 shares or 0% of all its holdings. Swiss Fincl Bank reported 89,000 shares stake. Gsa Ptnrs Llp holds 0% of its portfolio in GenMark Diagnostics, Inc. (NASDAQ:GNMK) for 14,196 shares.

Point72 Asia Hong Kong Ltd, which manages about $295.77M US Long portfolio, decreased its stake in Pulte Group Inc (NYSE:PHM) by 21,707 shares to 846 shares, valued at $24,000 in 2018Q2, according to the filing. It also reduced its holding in F M C Corp (NYSE:FMC) by 4,246 shares in the quarter, leaving it with 3,370 shares, and cut its stake in Synopsys Inc (NASDAQ:SNPS).

Among 22 analysts covering JD.com (NASDAQ:JD), 13 have Buy rating, 0 Sell and 9 Hold. Therefore 59% are positive. JD.com had 60 analyst reports since August 4, 2015 according to SRatingsIntel. TH Capital initiated JD.com, Inc. (NASDAQ:JD) rating on Tuesday, August 4. TH Capital has “Buy” rating and $39 target. The rating was maintained by Bernstein with “Hold” on Wednesday, January 31. Stifel Nicolaus maintained JD.com, Inc. (NASDAQ:JD) on Tuesday, January 16 with “Buy” rating. The rating was maintained by JP Morgan on Monday, March 5 with “Overweight”. The stock of JD.com, Inc. (NASDAQ:JD) has “Overweight” rating given on Friday, August 17 by KeyBanc Capital Markets. The stock has “Buy” rating by Nomura on Thursday, August 11. The firm earned “Neutral” rating on Thursday, August 11 by Bank of America. The rating was maintained by Jefferies with “Buy” on Tuesday, August 22. On Thursday, August 11 the stock rating was maintained by Jefferies with “Buy”. The company was upgraded on Monday, October 30 by UBS.

More notable recent JD.com, Inc. (NASDAQ:JD) news were published by: Nasdaq.com which released: “Apple, JD.Com Fall as U.S. Stocks Come Under Pressure Again – Nasdaq” on November 19, 2018, also Seekingalpha.com with their article: “JD.com After The Crash: Hold Or Fold? – Seeking Alpha” published on December 04, 2018, Seekingalpha.com published: “JD.com’s Earnings: Focus On These 3 Metrics – Seeking Alpha” on November 15, 2018. More interesting news about JD.com, Inc. (NASDAQ:JD) were released by: Seekingalpha.com and their article: “JD.com: All The Issues (And How To Read Them) – Seeking Alpha” published on November 29, 2018 as well as Nasdaq.com‘s news article titled: “Earnings Reaction History: JD.COM INC-ADR, 54.5% Follow-Through Indicator, 4.8% Sensitive – Nasdaq” with publication date: November 19, 2018.

GenMark Diagnostics, Inc. (NASDAQ:GNMK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.